Ausgabe 8/2014
Inhalt (7 Artikel)
Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved
Rui Li, Hugh A. Barton, Manthena V. Varma
A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring
Tony K. L. Kiang, Urs O. Häfeli, Mary H. H. Ensom
Pharmacokinetics of Orally Administered Duloxetine in Children and Adolescents with Major Depressive Disorder
Evelyn D. Lobo, Tonya Quinlan, Apurva Prakash
Characterisation of the Clinical Pharmacokinetics of Actinomycin D and the Influence of ABCB1 Pharmacogenetic Variation on Actinomycin D Disposition in Children with Cancer
Christopher R. Hill, Michael Cole, Julie Errington, Ghada Malik, Alan V. Boddy, Gareth J. Veal
Levofloxacin Dosing Regimen in Severely Morbidly Obese Patients (BMI ≥40 kg/m2) Should Be Guided by Creatinine Clearance Estimates Based on Ideal Body Weight and Optimized by Therapeutic Drug Monitoring
Manjunath P. Pai, Piergiorgio Cojutti, Federico Pea
Why Dried Blood Spots Are an Ideal Tool for CYP1A2 Phenotyping
Pieter M. M. De Kesel, Willy E. Lambert, Christophe P. Stove